These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7047466)

  • 1. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy.
    Haumont D; Dorchy H; Toussaint D; Despontin M
    Helv Paediatr Acta; 1982 May; 37(2):143-50. PubMed ID: 7047466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ; Medbak S; Drury PL; Cudworth AG
    Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On C-peptide and some other parameters in children with insulin dependent diabetes mellitus (author's transl)].
    Koepp P; Kühnau J
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):215-7. PubMed ID: 7048078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of diabetic microangiopathy. Fluoroangioretinal observations during monocomponent insulin therapy].
    Anselmetti G; Antoniotti V; Barbero PL; Castellazzi R; Gamba S; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(1-6):47-68. PubMed ID: 756200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 9. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prognosis of insulin-dependent diabetes mellitus].
    Deckert T
    Z Gesamte Inn Med; 1981 Jan; 36(1):4-8. PubMed ID: 7013293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of peptide C determination in diabetes].
    Halaby G; Karam J; Jambart S; Aydenian H; Zankoul R; Gannagé MH
    J Med Liban; 1989; 38(1):29-34. PubMed ID: 2519329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic retinitis in children and adolescents and its relationship to regulation (author's transl)].
    Hoffmann K; Gilde K; Hürter P; Jost J
    Klin Monbl Augenheilkd; 1980 Oct; 177(4):482-6. PubMed ID: 6166786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between diabetics receiving a high or low daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Smythe P; Binder C; Fabero OK
    Horm Metab Res; 1978 Sep; 10(5):365-9. PubMed ID: 568594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
    Bemm H; Lohmann D
    Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of anti-insulin-antibodies.
    Andersen OO
    Acta Endocrinol Suppl (Copenh); 1976; 205():231-40. PubMed ID: 1087092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of human insulin in 3 patients with diabetes mellitus and insulin resistance].
    Khristov V; Manov A
    Vutr Boles; 1989; 28(1):51-6. PubMed ID: 2662609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E; Sabuncu T; Ozer EM; Hatemi H
    J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy.
    Taverna MJ; Sola A; Guyot-Argenton C; Pacher N; Bruzzo F; Slama G; Reach G; Selam JL
    Diabetologia; 2002 Mar; 45(3):436-42. PubMed ID: 11914750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.